[{"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":148600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":150300000.0,"RevenuesConverted_3_Q3_USD":8247900000.0,"RevenuesConverted_1_Q3_USD":2778900000.0,"Assets_0_Q3_USD":23806700000.0,"NetIncomeLossConverted_1_Q3_USD":318100000.0,"StockholdersEquity_0_Q3_USD":10429900000.0,"EarningsPerShareDiluted_3_Q3_USD":7.9,"EarningsPerShareDiluted_1_Q3_USD":2.22,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":2801600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":149900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":148000000.0,"StockholdersEquityConverted_0_Q3_USD":10881700000.0,"NetIncomeLossConverted_3_Q3_USD":1187900000.0,"EarningsPerShareBasic_1_Q3_USD":2.22,"EarningsPerShareBasic_3_Q3_USD":7.93,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20211020"}]